title: Vaccination with type III secreted proteins leads to decreased shedding in calves after experimental infection with Escherichia coli O157.
abstract: Escherichia coli O157:H7 remains a threat to humans via cattle-derived fecal contamination of food and water. Preharvest intervention strategies represent a means of reducing the pathogen burden before harvest. In this study, the efficacy of a commercially produced type III secreted protein (TTSP) vaccine was evaluated with the use of a commingled experimental calf infection model (30 placebo-treated animals and 30 vaccinates). The calves were vaccinated on days 0, 21, and 42 and infected with 10(9) colony-forming units (CFU) of E. coli O157 by oral-gastric intubation on day 56. Fecal shedding was monitored daily for 14 d. Serologic assessment revealed a robust immune response to vaccination; the serum titers of antibodies against EspA, Tir, and total TTSPs were significantly higher in the vaccinates than in the placebo-treated animals on days 21, 42, 56, and 70. Significantly less (P = 0.011) of the challenge organism was shed by the vaccinates than by the placebo-treated animals on days 3 to 10. Peak shedding occurred in both groups on days 3 to 6; during this period the vaccinates showed a mean log reduction of 1.4 (P = 0.002) and a mitigated fraction of 51%. The number of animals shedding was significantly lower among the vaccinates compared with the placebo group on days 3 to 6 (P ≤ 0.05), with a mean prevented fraction of 21%. No differences in the duration of shedding were observed. Owing to the low challenge shedding in both groups on days 11 to 14 (mean CFU/g < 10; median = 0), no significant differences were observed. These data indicate that TTSP vaccination had protective effects through significant reductions in the number of animals shedding and the number of challenge organisms shed per animal and provides evidence that TTSP vaccination is an effective preharvest intervention strategy against E. coli O157.
authors: Bioniche Life Sciences, 231 Dundas St. East, Belleville, Ontario K8N 1E2. allen12@mail.ubc.ca
authors: Kevin J
authors: KJ
authors: Allen
authors: Dragan
authors: D
authors: Rogan
authors: B Brett
authors: BB
authors: Finlay
authors: Andrew A
authors: AA
authors: Potter
authors: David J
authors: DJ
authors: Asper
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D057138:Bacterial Shedding; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood / Q000276:immunology*; D004927:Escherichia coli Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D019453:Escherichia coli O157 / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology*; D029968:Escherichia coli Proteins / Q000276:immunology*; D022361:Escherichia coli Vaccines / Q000276:immunology*; D005243:Feces / Q000382:microbiology; D014611:Vaccination / Q000379:methods / Q000662:veterinary*
chemical_list: D000907:Antibodies, Bacterial; D029968:Escherichia coli Proteins; D022361:Escherichia coli Vaccines